1[1]Bates DW,Cullen D,Laird N,et al.Incidence of adverse drug event and potential adverse drug events:implication for prevention.JAMA,1995,274:29-34
2[2]Bates DW,Miller EB,Cullen DJ,et al.Patient risk factors for adverse drug events in hospitalized patients.Arch Intern Med,1999,159:2553-2560
3[3]Gurwitz JH,Field TS,Harrold LR,et al.Incidence and preventability of adverse drug events among older persons in the ambulatory setting.JAMA,2003,289:1107-1116
4[4]Naranjo CA,Busto U,Sellers EM,et al.A reliable method for estimating the probability of adverse drug reactions.Clin Phar Ther,1981,30:239-245
5[5]Schumock GT,Thoroton JP.Focusing on preventability of adverse drug reactions.Hosp Pharm,1992,27:538
6[6]Johnson JM,Tanner LA.Postmarketing surveillance:curriculum for the clinical pharmacologist,Part Ⅱ:Clinical and regulatory considerations.J Clin Pharmacol,1993,33:1015-1022
7[7]Gholame K,Shlviri G.Factors associated with preventability,predictability and severity of adverse drug reactions.Ann Pharmacother,1999,33:326-330
8[8]Pearson TF,Pittman DJ,Longley JM,et al.Factors associated with preventable adverse drug reactions.Am J Hosp Pharm,1991,51(18):2268-2272
9[9]Thomas EJ,Brennan TA.Incidence and types of preven-table adverse drug events in elderly patients:population based review of medical records.BMJ,2000,320:741-744
10[10]Bates DW,Spell N,Cullen DJ.The costs of adverse drug events in hospitalized patient.JAMA,1997,277:307-312
